News & Analysis as of

Insider Trading Clinical Trials

ArentFox Schiff

Insider Trading Based on Clinical Trial Information Remains Area of Vulnerability

ArentFox Schiff on

For decades, the Securities and Exchange Commission (SEC) and criminal prosecutors have pursued claims for insider trading in securities by persons who learn material nonpublic information about clinical drug trials. Every...more

Dorsey & Whitney LLP

Doctors Settle SEC Insider Trading Charges

Dorsey & Whitney LLP on

The Commission filed two settled insider trading cases against medical practitioners who traded while in possession of material non-public information regarding clinical trials for a drug. SEC v. Lama, Case No. 5:14-cv-00996...more

Dorsey & Whitney LLP

SEC Files Another Settled Insider Trading Case

Dorsey & Whitney LLP on

Insider trading continues to be a key priority in the new get tough enforcement era. Last week closed with the filing of an insider trading action centered on the BP oil spill in the Gulf of Mexico. This week begins with...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide